Dr. Felix Mahfoud

Felix Mahfoud

Interventional cardiologist / Cardiologist
Saarland University Hospital - HOMBURG, Germany

Declaration of interest

FunctionCompany
Grants/research supportMedtronic
OtherMedtronic

Latest contributions

SPYRAL HTN-OFF MED study - Will this trial change my practice

27 Jan 2018 – From AsiaPCR/SingLIVE 2018

Consult this session if you want to learn from the SPYRAL HTN-OFF MED study and how does this apply to my practice?

Clinical case

A case with mild-moderate uncontrolled hypertension due to multiple drug-intolerances

Frequent treatment dilemmas in coronary interventions

19 May 2017 – From EuroPCR 2017

Innovation for structural heart disease, heart failure and hypertension

18 May 2017 – From EuroPCR 2017

Clinical Research Forum on device-based therapies for hypertension – Update from the Clinical Consensus Conference on Device-based Hypertension Therapies

18 May 2017 – From EuroPCR 2017

Consult this session Clinical Research Forum on device-based therapies for hypertension with the collaboration of the Practical Course on Hypertension (PCH) if you want to find out more about patient recruitment for clinical trials, patient communication strategies and specific features of devices for hypertension treatment.

Device-based interventional therapies for hypertension – Part III – Renal angioplasty and arteriovenous-fistula creation

18 May 2017 – From EuroPCR 2017

Consult the Part III of the device-based interventional therapies for hypertension that focus on renal angioplasty and arteriovenous-fistula creation as presented during EuroPCR 2017 in collaboration with the Practical Course on Hypertension (PCH).

The year in intervention: essential publications from the EuroIntervention Journal and the European Heart Journal

18 May 2017 – From EuroPCR 2017

Device-based interventional therapies for hypertension – Part II – Catheter-based renal denervation

18 May 2017 – From EuroPCR 2017

Consult this session on Device-based interventional therapies for hypertension – Part II: Catheter-based renal denervation if you want to learn more about treatment recommendations of renal denervation systems.

With the collaboration of the Practical Course on Hypertension (PCH).

Device-based management in advanced acute heart failure: are we there yet?

18 May 2017 – From EuroPCR 2017

Device-based interventional therapies for hypertension – Part I – Carotid neuromodulation

18 May 2017 – From EuroPCR 2017

Consult this session on Device-based interventional therapies for hypertension – Part I: Carotid neuromodulation, if you want to discover more about neuromodulation and appreciate the different device features, procedural steps and clinical study results.With the collaboration of the Practical Course on Hypertension (PCH)

Renal denervation for hypertension: path ahead and what to expect from the ongoing clinical studies

18 May 2017 – From EuroPCR 2017

Resurrecting renal denervation: optimising the procedure

17 May 2017 – From EuroPCR 2017

Consult this session from EuroPCR 2017 on resurrecting renal denervation: optimising the procedure and discover the presentation by F. Ribichini on a patient with severe hypertension on multiple medications with branch treatment.

Device-based management in advanced chronic heart failure: update on clinical development and outcomes

17 May 2017 – From EuroPCR 2017

Device-based management in advanced chronic heart failure: are we there yet?

16 May 2017 – From EuroPCR 2017

Novel insights from renal denervation studies

16 May 2017 – From EuroPCR 2017

Coronary interventions in patients with diabetes and kidney dysfunction

16 May 2017 – From EuroPCR 2017

Innovations at the crossroad: heart failure management

15 May 2017 – From PCR Innovators Day Paris 2017

Consult this innovation session on heart failure management presented by M. Berenger, H. Rowland and V. Tuseth on which approaches will work.

New insights in renal denervation

19 May 2016 – From EuroPCR 2016

Roland Schmieder

Chairperson

Roland Schmieder

Catheter-based renal denervation exchange forum around the globe: building the future By and For your experience

18 May 2016 – From EuroPCR 2016

Resistant hypertension management

18 May 2016 – From EuroPCR 2016

Dr. Felix Mahfoud

Chairperson

Felix Mahfoud
Flavio RIBICHINI

Chairperson

Flavio Ribichini

Critical appraisal of devices for the management of hypertension

18 May 2016 – From EuroPCR 2016

Dr. Felix Mahfoud

Chairperson

Felix Mahfoud
Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher

Renal and peripheral interventions

17 May 2016 – From EuroPCR 2016

Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher
Dr. Felix Mahfoud

Chairperson

Felix Mahfoud

Mid- and long-term outcome after renal denervation

17 May 2016 – From EuroPCR 2016

Chairperson

Faisal Sharif

Theme 2: heart failure interventions

16 May 2016 – From EuroPCR 2016

Antoine Papiernik

Chairperson

Antoine Papiernik
Alexander Schmitz

Chairperson

Alexander Schmitz

Interventions in patients with heart failure and resistant hypertension

21 May 2015 – From EuroPCR 2015

Catheter-based renal sympathetic denervation - Procedural aspects: time to revise treatment recommendations?

21 May 2015 – From EuroPCR 2015

Thomas Zeller

Chairperson

Thomas Zeller

Can new concepts revitalise catheter-based renal denervation therapies?

21 May 2015 – From EuroPCR 2015

Dr. Paul Ong

Chairperson

Paul Ong

Interventional hypertension treatment - Moving forward

20 May 2015 – From EuroPCR 2015

Catheter-based renal sympathetic denervation: a comprehensive update in 2015

20 May 2015 – From EuroPCR 2015

Treating hypertensive patients at risk

20 May 2015 – From EuroPCR 2015

Roland Schmieder

Chairperson

Roland Schmieder

Addressing key questions on renal denervation with the SPYRAL HTN global clinical trial programme

20 May 2015 – From EuroPCR 2015

Dr. Felix Mahfoud

Chairperson

Felix Mahfoud